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Hemopoiesis in the Thymus
MARION D. KENDALL
Thymus Laboratory, The Babraham Institute, Cambridge CB2 4AT, and Pharmacology Department, UMDS, London SE1 7EH, UK
The presence in the thymus of hemopoietic cells other than thymocytes has been known for
many years, but the extent of the hemopoietic activity of the thymus and the possible
functional implications have only recently begun to receive much attention. This review
summarizes the literature in this field, especially in the light of current cytokine and
thymic-factor knowledge, and includes clinical relevance where possible.
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INTRODUCTION
The thymus is the major site for T-cell development,
but that it may act as a site for other forms of
hemopoiesis in all vertebrates, although regularly
documented over the years, has been largely ig-
nored. With the growth of good lineage markers for
blood cells, it has been found that the thymus
contains a range of different hemopoietic cells, often
proliferating or developing in situ. In some cases,
this has clinical significance, but in others, it may
appear almost accidental or only manifest itself in
abnormal situations. In any case, the occurrence of
non-T-cell hemopoiesis can be used to explore the
microenvironment and to give an indication of the
interactive function of factors such as cytokines.
This may benefit the clinical management of certain
diseases and give hope for the manipulation of
immune responses. This review therefore considers
factors that may predispose toward the develop-
ment of various hemopoietic cells in the thymus,
and then discusses the presence and development of
B, plasma, erythroid, and mast cells, eosinophils and
neutrophils. Other hemopoietic cells are not in-
cluded here, although they could also develop in the
thymus. This is particularly true for natural killer
and lymphokine-activated killer cells, but there is
very little information about other cells, such as
basophils, in the thymus.
Of critical importance in thymic hemopoiesis is
the presence and potential of primitive stem/
precursor/progenitor cells within the thymus and
the local action of certain cytokines. In addition to
the problems of finding adequate lineage markers
for primitive cells, it is clear that different studies
highlight, sometimes contradictory, findings. This
may be a reflection of thymic embryological deve-
lopment. Hemopoiesis first occurs in the yolk sac,
and cells from this extra-embryonic site migrate to
the liver. Shortly after this, hemopoietic cells appear
in the developing thymus, in some long bones (e.g.,
clavicle) and elsewhere (e.g., kidney). The thymus in
the human embryo is hemopoietic (mainly lym-
phoid) by about 8 weeks, and is the most important
hemopoietic organ throughout gestation (Kelemen
et al., 1979). Full bone marrow development in the
long bones occurs much later, and in the adult
mouse, 1 in 10,000 bone marrow cells have been
described as thymic colony forming units (Span-
grude and Scollay, 1990). Recent research on the
capabilities of stem cells populating the early mouse
embryo has shown that the thymus rudiment is
seeded by multipotential precursor cells that are not
immediately committed to T-cell development in the
thymic cellular environment (Peault et al., 1994). It
is therefore quite possible that T-lymphocyte pre-
cursors in the embryo and in the adult differ in their
capabilities, so that a concept of multipotential and
nonlineage-restricted precursors in the embryonic
thymus, and primarily T-lineage-restricted precur-
sors in the adult is quite plausible. Indeed, Span-
grude et al. (1988) demonstrated that the adult
mouse has two lineages of two similar cells but Sca-
also had CFU-S (colony forming units--spleen)
capabilities and were probably on the erythroid
line of development. Alternatively, truly multi-
potential stem cells of the embryo might remain
in the thymus in adult life, and on occasion be
157158 M.D. KENDALL et al.
"awakened". Indeed, variations on the extent to
which this might happen could be the key to many
of the observations quoted in this review.
Of considerable potential for elucidating stem-cell
biology is the identification of the ligand for the
c-kit tyrosine kinase receptor (Huang et al., 1990).
This is a glycoprotein that was previously called the
mast-cell growth factor (MGF), the stem-cell factor
(Zsebo et al., 1990), and the steel factor (Matsui
et al., 1991). Stem-cell factor (SCF, a form of the
c-kit ligand) alone or in combination with various
factors (the interleukins IL-3, IL-6, IL-11, erythro-
poietin, and granulocyte colony-stimulating factor,
or G-CSF) stimulates myelopoiesis, including eryth-
ropoiesis, as well as T- and B-cell development. It
appears to be produced by a variety of cells, and one
form (KL-1) is especially associated with fibroblasts,
brain, and thymus (Huang et al., 1992).
Another facet of the thymus is that there may be
major microenvironment differences between major
lobes (left and right thymuses), as seen in repopu-
lation studies (Ezine et al., 1984) or diseases such as
myasthenia gravis (MG), as well as variations be-
tween lobes of either the left or right thymus.
Furthermore, because cytokines largely shape the
microenvironment, small areas within the thymus
may change rapidly from day to day, or more slowly
with age and physiological rhythms, under stress,
disease, or as a result of the administration of drugs
or toxic compounds. Thus, alterations in their levels
could have profound effects on hemopoietic-lineage
development.
A cytokine of major importance in hemopoiesis is
IL-3. It is a multipotential cytokine stimulating the
proliferation and differentiation of pluripotent hemo-
poietic stem cells and lineage-committed precursors
of granulocytes, macrophages, eosinophils, erythro-
cytes, megakaryocytes, mast cells, and lymphoid
cells. It is a factor for mast cell growth, is a multi-
colony stimulating factor, has burst-promoting ac-
tivity, and is Thyl-inducing. It is produced mainly
by activated T-cells and mast cells, but, of impor-
tance here, also by thymic epithelium. Its actions
often need synergy from other factors (IL-1, IL-6,
IL-11, c-kit ligand, G-CSF- 1).
IL-4, another activated T-cell factor, was primarily
found to act on B-cell differentiation (BCDF) and
growth factor (BCGF1). However, it also acts on
other hemopoietic cells such as T-, mast, and
monocyte-lineage cells. In synergy with other cy-
tokines such as IL-11, it enhances the proliferation
of primitive and committed progenitors. The IL-4R
molecule occurs widely on cortical epithelial cells
(and some thymocytes) in the human thymus, so
this cytokine could be involved in regulation of
hemopoiesis within the thymus.
The T-cell-derived, B-cell growth factor for mu-
rine cells, IL-5, also has the ability to act as an
eosinophil differentiating factor, albeit a late-acting
cytokine. Whether this cytokine has been found to
act within the thymus is not clear. In humans, some
of the B-cell differentiation effects are actually car-
ried out by IL-6. This factor has colony-stimulating
actions on hemopoietic stem cells, and is known to
act on thymocytes.
Even when the action of single cytokines has been
defined, other roles emerge and they all interact to
synergize and suppress other hemopoietic factors.
IL-7, which was originally implicated in B-cell de-
velopment, has been shown to be expressed in the
thymus by cortical epithelial cells from fetal and
neonatal thymuses (Moore et al., 1993). IL-7 and
SCF are involved in T-cell development although
they cannot support differentiation. GM-CSF, the
granulocyte/macrophage-CSF, also causes prolifer-
ation of erythroid, dendritic, and megakaryocyte
precursors. Both GM-CSF and IL-I are poorly
expressed by cortical epithelial cells. When cloned
human thymic epithelial cells were challenged with
IL-I, the production of GM-CSF, granulocyte-CSF,
and other cytokines was strongly upregulated (Galy
and Spitz, 1991). It is not known if granulocyte-CSF
(G-CSF) is produced in the thymus, as it is mainly
produced by activated macrophages. With stem-cell
factor, it may cause proliferation of early stem cells
as well as primarily acting to stimulate neutrophil
colony formation from bone marrow derived cells.
Finally, it has been recently suggested that CD69,
which is expressed transiently in recently activated
lymphocytes, may also be a marker of positively
selected thymocytes, and has now been found on
many hemopoietic cells. Cross-linking CD69 results
in an intracellular signal in all systems investigated,
so Testi et al. (1994) have suggested that CD69
molecules could act as common triggers for a variety
of hemopoietic cells at different stages of their
development, and therefore be of wide biological
significance.
B CELLS AND PLASMA CELLS
Thymic tissue has been used by many researchers as
a source of mast-cell precursors (Ginsburg andHEMOPOIESIS IN THE THYMUS 159
Sachs, 1963; Ishizaka et al., 1976), and the presence
of immature cells within the gland is indicative of
intrathymic development (Kendall and Warley,
1986). Both B- and plasma cells occur in the normal
and diseased thymus. B-cells have a high rate of
proliferation there (Pabst et al., 1989), and are
generally concentrated in the medulla (Isaacson
et al., 1987), and at the cortico-medullary junction,
whereas plasma cells are found predominantly in
the cortex (Clarke and Kendall, 1989; Abou-Rabia
and Kendall, 1994). Perivascular spaces may contain
both B-cells and plasma cells. Initially, B-cells were
thought to be casual components of the thymus, but
then as their functions became clearer, other possi-
bilities arose. Might their presence indicate that
immune responses could be enacted within the
organ? Some evidence for this exists. Benner et al.
(1974) presented evidence for thymic participation
in the immune response (antibody formation,
evidence of plasma cells and phagocytosis) after
antigen dosing. In these cases, would T-cell devel-
opment be affected? On the other hand, perhaps
B-cells are necessary for T-cell development and
their antigen-presenting capacity might influence
repertoire selection. Thymic plasma cells are also a
mystery. Benner et al. (1974) also showed antibody-
plaque-forming cell activity in the thymus after
antigen challenge, so the plasma cells probably
secrete antibody. But is this a normal part of thymic
activity, or does this only occur in disease?
B-cell activity in the immune response is generally
associated with germinal centers in lymph nodes, so
the thymus has been extensively studied in this
respect. It is often assumed that thymic germinal
centers are associated with autoimmune conditions,
especially MG and systemic lupus erythematosus
(SLE). However, germinal centers also occur in the
thymus under normal conditions (Middleton, 1967;
Hofmann et al., 1988; Wirt et al., 1988; Kupper et
al., 1989) as well as in disease (Vetters and
Barclay,1973; Rosai and Levine, 1976; Vincent et al.,
1978; Fujii et al., 1983; Williams and Lennon, 1986).
Furthermore, their frequency of appearance can be
similar: Middleton (1967)recorded germinal centers
in the thymus of 71.7% of adults 0-39 years old
who died accidentally--a level of incidence compa-
rable to that of MG patients.
A detailed immunocytoch’emical investigation
(Wirt et al., 1988) of B-cells in nonimmunological
disease (19 cases and 1 MG patient) found 25% of
the patients’ thymuses had active B-cell zones in
medullary septa arranged as follicles. Each had an
outer mantle showing IgD positivity and an inner
germinal center containing dendritic reticular cells.
The follicles expressed IgG, IgM, kappa, and lambda
in a lacy interstitial pattern. The T-cells in the
follicles were predominantly Leu3
/ helper/inducer
cells and some were Leu7 cells (a T-cell subset
and/or NK cells). All 20 thymuses examined
showed a substantial minority of scattered B-cells in
the septa and medulla that had the phenotype of
circulating blood B-cells. This suggests that traf-
ficking of B-cells into the medulla is common.
Abou-Rabia and Kendall (1994) document the
passage of cells through medullary endothelia in
hypothyroidism.
The thymuses in certain models for autoimmune
diseases may carry very high levels of B-cells. The
mouse model for SLE has B-cells in the thymus long
before the clinical demonstration of disease (Farinas
et al., 1990). However, in AKR mice (prone to
retrovirus associated lymphomas), an increased
presence of peripheral T- and B-cells in hyperplastic
and preneoplastic thymuses was postulated to be
associated with a response to local antigenic stimu-
lation (Michie and Rouse, 1991). Cells bearing the
MEL-14 (L-selectin) homing receptor (the majority
of B-cells in hyperplastic thymuses) were predomi-
nantly located around follicles in the enlarged
medulla.
MG patients generally have hyperactive thymus
glands with many showing germinal centers. Their
B-cells (CD19/, CD21 /, and IgD or IgM/) are
activated (Leprince et al., 1990), produce anti-AChR
antibodies in vitro, and their levels correlate with
sera autoantibody titer and abnormal thymic histol-
ogy (Safar et al., 1987). In patients with rheumatoid
arthritis, peripheral CD5 B-cells secrete rheuma-
toid factor.
A more recent study on the properties of human
thymic B-cells (Spencer et al., 1992) gives a higher
representation of B-cells (CD20 /) in sections of
thymic medulla (33 +4.8%) than the Wirt study
(which was not quantified), and also shows them
to be activated B-cells (CD19 /, CD20/, CD22 /,
CD35-, CDw32-) with about 10% expressing an
indicator of cellular division (Ki67 ). The medullary
B-cells often formed rosettes with thymocytes sup-
porting the hypothesis that thymic B-cells are pre-
senting autoantigens to thymocytes as part of the
negative selection process. This seems plausible
following murine studies of negative selection with
the V chain-bearing T-cells and Mls-determinant
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macrophages, dendritic cells, or T-cells) have the
Mls locus and are found early in ontogeny in the
thymus, probably before B-cell development in the
liver (Nango et al., 1991). Both B-cells and dendritic
cells are required in vitro for clonal deletion in mice
(Mazda et al., 1991). In vivo, however, thymic
B-cells alone delete Mls-reactive T-cells, and induce
tolerance with injected dendritic cells, while den-
dritic cells alone energized V6 cells (Inaba et al.,
1991), although the processes may be more compli-
cated. It is now emerging that, at least in mice, the
role of mature B-cells in controlling V deletion is
variable. V11 cells require B-cell contact for de-
letion unlikeV3
/ andV5 cells (Frey et al., 1992).
Thus, B-cells are important for shaping the reper-
toire of T-cells to both internal and external anti-
gens, and in establishing tolerance (Zoller, 1990).
A further complication in evaluating B-cell func-
tion is that in humans and mice, more than one type
of B-cell exists. Human thymic medullary B-cells are
heterogenous and may bear the CD76 antigen that
appears late in maturation. They also differ pheno-
typically from follicle mantle and germinal center
cells (Fend et al., 1991). In the mouse, thymic B-cells
(CD5/) differ from peritoneal cavity B-cells in sev-
eral respects, especially in their inability to sponta-
neously produce autoantibodies (Than et al., 1992).
Mouse thymic B-cells can be stimulated with MHC
class II-restricted CD4 blasts and they then secrete
IgM (Inaba et al., 1990), but they fail to respond to
LPS or to anti-IgM plus IL-4. The cytokines IL-4 and
IL-7 have both been shown to play a part in B-cell
isotype switching and Ig production in vitro (Vande-
kerchhove et al., 1993). B-cells may also differ in
their origins as thymic, but not peritoneal cavity
B-cells can be reconstituted after irradiation and
bone marrow transplantation. In this respect, thy-
mic B-cells resemble conventional B-cells. Also fetal
and adult hemopoietic stem cells have been shown
to differ in their potential (Ikuta et al., 1990), so it
has been proposed (Than et al., 1992) {hat fetal stem
cells can give rise to conventional B-cells that be-
come thymic or peritoneal cavity B-cells, but adult
hemopoietic stem cells cannot form peritoneal cavity
B-cells.
Whereas the preceeding studies indicate but do
not prove that thymic B-cells are developed within
the thymus, low frequencies of B-lineage cells (sus-
ceptible to viral transformation) are present from
days 13-14 of gestation in mice. Whether these
have immigrated as multipotential stem cells or as
committed B-lineage cells is not known. Their
frequency rapidly increases to at least 1 in 500 cells
at days 15-16, which is an order of magnitude
higher than similar cells in fetal liver or adult bone
marrow (Kimoto et al., 1989). Mouse thymic B-cells
(which are CD5 /, unlike human thymic, and other
mouse lymphoid organ B-cells) are the first B-cells
after birth to secrete IgG (Andreu-Sanchez et al.,
1990), and a B-lineage transformation-associated
antigen (6C3) appears on murine cortical epithelial
cells 1-2 weeks after birth (Adkins et al., 1988). This
antigen is also found in kidney and intestine, but in
the lymphoid system, only in thymus and bone
marrow, where it supports pre-B-cell proliferation
and differentiation in vitro (Whitlock et al., 1987).
The capacity of the thymic stroma to allow B-cell
development (as seen morphologically) is supported
by the findings that neonatal thymectomy causes a
sudden disappearance of circulating B-cells (Sprent,
1973), and reconstitution with mature T-cells par-
tially rectifies the B-cell deficiency in X-linked im-
mune deficient (xid) mice (Sprent and Bruce, 1984).
Further work with xid mice (Karagogeos and Wortis,
1987) showed that maturation of xid B-cells past the
pro-B or early pre-B cell is T-cell-dependent, so the
necessary factors could be within the thymus.
ERYTHROPOIESIS
Several early morphological studies refer to the
presence of immature red cells within the thymus,
and their occurrence was convincingly documented
by Albert et al. (1965a, 1965b, 1966) in mice and
man. Generally, fetal, pediatric (Taylor and Skinner,
1976), and lower vertebrate (Kendall, 1980a) thy-
mus glands exhibit most erythropoiesis, and the
levels in adult man may be low (Kendall and Singh,
1980). However, because the morphology of early
erythroid cells is very similar to lymphoid cells, it is
only when specific techniques for identifying eryth-
roid cells are employed that the extent of erythro-
poiesis may be recognized (Kendall, 1975; Borgeois
et al., 1981; Kendall et al., 1985).
In several wild bird species, thymic erythropoiesis
is a regular occurrence, especially during breeding
and moult (Kendall and Ward, 1974; Bacchus and
Kendall, 1975; Kendall, 1975a, 1975b, 1979; Ward
and Kendall 1975; Kendall and Frazier, 1979; Fron-
fria et al., 1985). It has been most extensively
studied in the red-billed quelea, Quelea quelea (Fig.
1). The young after hatching (Fig. la) have very
enlarged thymic lobes (birds usually have two162 M.D. KENDALL et al.
(a) (b)
(c)
FIGURE 2. Erythropoiesis and apoptosis in the thymic cortex.
(a) higher-power view of a thymic lobe from a junvenile Q. quelea
with an involuting gland (similar to Fig. lb). Note the very high
level of apoptotic cells, many of which are dying early erythroid
cells. 8-m paraffin section, Masson’s Trichrome stain, x 1200.
(b) The erythropoietic thymic cortex from a breeding adult as
shown in Figs. lc and d. Araldite embedded 1-m section
stained with toluidene blue. x 480. (c) The cortex of a wild Bank
vole thymus to illustrate erythropoiesis, and a macrophage full of
apoptotic cells. (For details, see Kendall, 1980.) Azur II-stained
1-m thick araldite section, x 1200.
Anon., 1959; Jacobs et al., 1959; Parry et al., 1959;
Krantz, 1990). The relationship, if any, between
removal of the thymus and the restoration of nor-
mal erythroid levels in these rare diseases is unclear,
but the recognition that thymocytes can enhance or
suppress erythroid colony growth may be relevant
(Sharkis et al., 1986).
MAST CELLS
Mast cells in most species display marked functional
and morphological heterogeneity. The characteris-
tics of different mast cell types has been mainly
explored in rodent models and mast cell cultures.
This has led to a recognition of bone marrow
derived cultured mast cells (BMCMCs) from rat
hemopoietic tissues (including the thymus),
connective-tissue mast cells (CTMCs), and mucosal
mast cells (MMCs). All of these are considered to be
the progeny of multipotential stem cells (Kitamura
et al., 1981). How separate the different types are, is
not clear because BMCMCs have been shown to
differentiate into CTMC-like cells (Nakano et al.,
1985), and peritoneal CTMCs under certain culture
conditions become MMC-like. Upon transfer to
mast cell-deficient mice, these MMC-like cells
become CTMCs. Thus, the microenvironment is
very important in the development of mast cell
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FIGURE 3. Electron micrograph of a sparrow thymus (Passer domesticus) showing an area of cortex almost entirely filled with
erythrocytes. There are no thymocytes in this region, epithelial cells remain, and occasional large mononuclear cells are also present.
Other nearby erythropoietic regions contained eosinophils and heterophils. (See Kendall, 1979.) x 8100.
Mast cells are commonly found in the capsule
around the thymus and along the connective tissue
septa within the gland (Frazier, 1973; Kendall and
Warley, 1986; Wight, 1970). Mast cells actually
within the stromal compartment (Figs. 4a and 4b)
are less common except in some unusual cases, e.g.,
NZB mice where enormous n.umbers of mast cells
proliferate in the cortex (Burnet, 1965), in the me-
dulla in dystrophic chicken (Befus et al., 1981), and
in induced anemia (Kendall and Blackett, 1983).
Further evidence for the presence of mast cell pre-
cursors in the thymus comes from several studies
where thymic tissues have been used as a source for
the in vitro development of mast cells (Ginsburg and
Sachs, 1963; Ishizaka et al., 1976), and an estimate
of 17 mast cell precursors/106 thymic cells has been
suggested (Kawashini et al., 1986). In other studies,
X-ray microanalysis has been used to study thymic
mast cell granules and the variation in potassium
and sulfur content suggests the presence of imma-
ture cells in rat thymus (Kendall and Warley, 1986).
Birds with the hereditary condition of muscular164 M.D. KENDALL et al.
FIGURE 4. Hemopoiesis in the cortex of the thymus in a bank
vole after induced anemia (reproduced with permission from
Kendall and Blackett, 1983). (a) An immature mast cell (M, top
left), numerous multilobed eosinophils (e), an immature neutro-
phil (N, top, off center), and a more mature multilobed neutrophil
(N, center right), x 3000. (b) An immature mast cells illustrating
the formation of the characteristic granules, x 12,600.
dystrophy have thymic abnormalities including de-
ficiencies in thymic mast cell numbers and hista-
mine content.
Studies with athymic and thymic rats suggest that
the thymus may regulate mast cells by an inhibitory
factor acting on the bone-marrow stem cell or
recirculating precursor pool (Aldenborg and Ener-
back, 1985).
Because parasite infestations often cause massive
mast cell development, the factors involved in mast
cell differentiation have been widely studied.
Of particular importance is that there is no MMC
proliferation in T-depleted mice and rats (Ruitenberg
and Elgesma, 1976; Mayrhofer and Fisher, 1979),
indicating T-cell dependence. The T-cell cytokines,
IL-3, IL-4, IL-9, and IL-10, have all been shown to
be involved in mast cell growth, and IL-3 injected
into nude (athymic) mice results in MMC develop-
ment (Abe et al., 1988). However, mutant mice with
defects of the c-kit proto-oncogene (W locus on
chromosome 5) have T-cells that produce IL-3 but
lack proper mast cell development. In culture, IL-4
is synergistic to the actions of IL-3-dependent pro-
liferation of mast cells, but does not alone maintain
high levels of the cells. IL-4 also stimulates the
production of B-cells and of importance perhaps to
mast cells, IgE synthesis (Paul and Ohara, 1987).
IL-9 was found to be identical with mast cell
growth-enhancing activity (MEA). Although it does
not itself enhance proliferation of BMCMC, it does
increase IL-3-dependent proliferation. Similarly, IL-
l0 alone is not proliferative, but does give optimal
growth in combination with IL-3 and IL-4. This trio
of cytokines is characteristic of activated T-cells, and
may be of greatest importance in certain immune
reactions, especially parasitic infections.
OTHER GRANULOCYTES
Granulopoiesis is the thymus has been extensively
documented since the late 1800s (see Bhatal and
Campbell, 1965). More recently, granulocyte deve-
lopment has been shown in rodents (Sin and Sainte-
Marie 1965; von Haelst, 1967; Kendall and Blackett,
1983; Kendall et al., 1985; Boshnakova, 1990)
humans (Downey, 1948; Bhatal and Campbell,
1965), cats (Pack and Chapman, 1980), and rabbits
(Downey, 1948; Westermann and Engelbert, 1969a,
1969b, 1969c). The embryonic and fetal stages of
many animals show development of granulocytes
within the thymus, and this activity may continue
into adult life. Westermann and Engelbert (1969a,
1969b) made a detailed study of the numbers and
distribution of different granulocytes (eosinophils of
two morphological forms, heterophils and baso-
phils) at different life stages and under conditions of
parasitic infection. The two forms of eosinophils
were regarded as arising from different precursors in
the thymus and it was found that their relative
numbers varied with parasitic infections. Young
rabbits had more eosinophils and fewer basophils
than younger animals, and old animals and para-
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granulocytes. The use of thymectomized rats (Basten
and Beeson, 1970) showed that the eosinophilia
induced by Nippostrongylus brasiliensis was under
T-lymphocyte control and this was confirmed in
athymic rats (Ogilvie et al., 1980; Letonja et al.,
1988). However, eosinophilia in the rat in response
to Fasciota hepatica is not thymus-dependent (Doy
and Hughes, 1982).
Immature and mature granulocytes are found in
the cortex (often the outer cortex, where myelocytes
can align themselves in rows under the capsule),
and in the medulla. In young animals and under
certain conditions in adults, such as induced anemia
(Fig. 4a), development occurs in nests of eosinophils
throughout the cortex (Kendall, 1978; Kendall and
Blackett, 1983; Kendall et al., 1985). Granulocytes in
the connective tissues of the septa and capsule are
generally recorded as more mature, and may be cells
entering or exiting the thymus. In many avian
thymuses, mature eosinophils were found within
vacuoles in or close to the necrotic center of Has-
sall’s corpuscles (Kendall and Frazier, 1979). Asso-
ciations of this nature were also observed in children
(Bhatal and Campbell, 1965; Muller, 1977) and in
rabbits (Westermann and Engelbert, 1969b). It has
been suggested that they may be phagocytosing
antigen-antibody complexes at this site because
both antigen (Marshall and White, 1961) and im-
munoglobulins (Henry and Anderson, 1990) accu-
mulate in Hassall’s corpuscles.
thymus also can support hemopoiesis in adult life.
Several important questions arise from this activity.
Does an imbalance in the body’s normal blood-cell
composition favor hemopoiesis in the thymus, and/
or do alterations to the thymic microenvironment
predispose to thymic hemopoiesis? Do foci of he-
mopoiesis depend on activation of previously dor-
mant multipotential stem cells or on the entry of
stem cells from the circulation? To what extent are
stem cells that may enter the adult thymus commit-
ted to develop into a specific lineage? However, now
that it is clear that the thymus microenvironment is
not restricted to T-cell development, the other he-
mopoietic activities will provide a rich research area
where progress should be rapid, because many of
the necessary tools are already available.
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